Comprehensive Genomic Evaluation of Osteosarcoma with a Targeted Next Generation Sequencing Assay Reveals Frequent Actionable Genomic Abnormalities and Potential New Routes to Targeted Therapies

被引：0
|
作者：
Niu, G. G.
Al-Rohil, R. N.
Vanushkina, M.
Sheehan, C. E.
Nazeer, T.
DiCaprio, M.
Palmer, G.
Ali, S. M.
Morosini, D.
Miller, V. A.
Stephens, P. J.
Ross, J. S.
机构：
[1] Albany Med Coll, Albany, NY 12208 USA
[2] Fdn Med Inc, Cambridge, MA USA
来源：
MODERN PATHOLOGY | 2014年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
82
引用
收藏
页码：23A / 24A
页数：2
相关论文
共 50 条
  • [1] Comprehensive Genomic Evaluation of Osteosarcoma with a Targeted Next Generation Sequencing Assay Reveals Frequent Actionable Genomic Abnormalities and Potential New Routes to Targeted Therapies
    Niu, G. G.
    Al-Rohil, R. N.
    Vanushkina, M.
    Sheehan, C. E.
    Nazeer, T.
    DiCaprio, M.
    Palmer, G.
    Ali, S. M.
    Morosini, D.
    Miller, V. A.
    Stephens, P. J.
    Ross, J. S.
    [J]. LABORATORY INVESTIGATION, 2014, 94 : 23A - 24A
  • [2] Comprehensive Genomic Profiling of Gastric Carcinoma by Next Generation Sequencing Reveals Frequent Actionable Genomic Abnormalities and New Routes to Targeted Therapies
    Ali, S. M.
    Wang, K.
    Otto, G. A.
    Palmer, G. A.
    Yelensky, R.
    Lipson, D.
    Morosini, D.
    Miller, V. A.
    Stephens, P. J.
    Ross, J. S.
    [J]. LABORATORY INVESTIGATION, 2014, 94 : 162A - 162A
  • [3] Comprehensive Genomic Profiling of Gastric Carcinoma by Next Generation Sequencing Reveals Frequent Actionable Genomic Abnormalities and New Routes to Targeted Therapies
    Ali, S. M.
    Wang, K.
    Otto, G. A.
    Palmer, G. A.
    Yelensky, R.
    Lipson, D.
    Morosini, D.
    Miller, V. A.
    Stephens, P. J.
    Ross, J. S.
    [J]. MODERN PATHOLOGY, 2014, 27 : 162A - 162A
  • [4] Evaluation of Gallbladder Adenocarcinoma by Next Generation Sequencing Reveals Frequent Actionable Genomic Abnormalities and New Routes to Targeted Therapies
    Tarasen, A. J.
    Al-Rohil, R. N.
    Wang, K.
    Rand, J. V.
    Jones, D. M.
    Lee, H. J.
    Sheehan, C. E.
    Otto, G. A.
    Palmer, G.
    Ali, S. M.
    Morosini, D.
    Miller, V. A.
    Stephens, P. J.
    Ross, J. S.
    [J]. MODERN PATHOLOGY, 2014, 27 : 205A - 206A
  • [5] Evaluation of Gallbladder Adenocarcinoma by Next Generation Sequencing Reveals Frequent Actionable Genomic Abnormalities and New Routes to Targeted Therapies
    Tarasen, A. J.
    Al-Rohil, R. N.
    Wang, K.
    Rand, J. V.
    Jones, D. M.
    Lee, H. J.
    Sheehan, C. E.
    Otto, G. A.
    Palmer, G.
    Ali, S. M.
    Morosini, D.
    Miller, V. A.
    Stephens, P. J.
    Ross, J. S.
    [J]. LABORATORY INVESTIGATION, 2014, 94 : 205A - 206A
  • [6] Comprehensive Genomic Profiling of Metaplastic Breast Carcinoma by Next Generation Sequencing Reveals Frequent Actionable Genomic Abnormalities and New Routes to Targeted Therapies
    Sheehan, C. E.
    Badve, S. S.
    Wang, K.
    Boguniewicz, A. B.
    Otto, G. A.
    Palmer, G.
    Yelenksy, R.
    Lipson, D.
    Ali, S. A.
    Morosini, D.
    Miller, V. A.
    Stephens, P. J.
    Ross, J. S.
    [J]. LABORATORY INVESTIGATION, 2014, 94 : 80A - 80A
  • [7] Comprehensive Genomic Profiling of Metaplastic Breast Carcinoma by Next Generation Sequencing Reveals Frequent Actionable Genomic Abnormalities and New Routes to Targeted Therapies
    Sheehan, C. E.
    Badve, S. S.
    Wang, K.
    Boguniewicz, A. B.
    Otto, G. A.
    Palmer, G.
    Yelenksy, R.
    Lipson, D.
    Ali, S. A.
    Morosini, D.
    Miller, V. A.
    Stephens, P. J.
    Ross, J. S.
    [J]. MODERN PATHOLOGY, 2014, 27 : 80A - 80A
  • [8] Evaluation of Cholangiocarcinomas (CCA) by Next Generation Sequencing (NGS) Reveals Frequent Actionable Genomic Abnormalities and New Routes to Targeted Therapies
    Al-Rohil, R.
    Rand, J. V.
    Jones, D. M.
    Lee, H. J.
    Sheehan, C. E.
    Otto, G.
    Palmer, G.
    Yelensky, R.
    Lipson, D.
    White, E.
    Balasubramanian, S.
    Garcia, L.
    Mahoney, K.
    Richards, T.
    Terzic, S.
    Banning, V.
    Curran, J.
    Downing, S.
    Miller, V.
    Stephens, P.
    Ross, J. S.
    [J]. LABORATORY INVESTIGATION, 2013, 93 : 397A - 397A
  • [9] Evaluation of Cholangiocarcinomas (CCA) by Next Generation Sequencing (NGS) Reveals Frequent Actionable Genomic Abnormalities and New Routes to Targeted Therapies
    Al-Rohil, R.
    Rand, J. V.
    Jones, D. M.
    Lee, H. J.
    Sheehan, C. E.
    Otto, G.
    Palmer, G.
    Yelensky, R.
    Lipson, D.
    White, E.
    Balasubramanian, S.
    Garcia, L.
    Mahoney, K.
    Richards, T.
    Terzic, S.
    Banning, V.
    Curran, J.
    Downing, S.
    Miller, V.
    Stephens, P.
    Ross, J. S.
    [J]. MODERN PATHOLOGY, 2013, 26 : 397A - 397A
  • [10] Targeted Next Generation Sequencing of Adenocarcinoma of Unknown Primary Site Reveals Frequent Actionable Genomic Abnormalities and New Routes to Targeted Therapies
    Ross, J. S.
    Wang, K.
    Otto, G. A.
    Palmer, G.
    Yelensky, R.
    Lipson, D.
    Chmielecki, J.
    Ali, S. M.
    Morosini, D.
    Miller, V. A.
    Stephens, P. J.
    [J]. LABORATORY INVESTIGATION, 2014, 94 : 529A - 529A
12345